| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | L-685458 | CCLE | pan-cancer | AAC | 0.079 | 0.2 |
| mRNA | nelarabine | CTRPv2 | pan-cancer | AAC | 0.061 | 0.2 |
| mRNA | Bexarotene | FIMM | pan-cancer | AAC | -0.29 | 0.2 |
| mRNA | WH-4-023 | GDSC1000 | pan-cancer | AAC | 0.084 | 0.2 |
| mRNA | SID 26681509 | CTRPv2 | pan-cancer | AAC | -0.058 | 0.2 |
| mRNA | triazolothiadiazine | CTRPv2 | pan-cancer | AAC | -0.045 | 0.2 |
| mRNA | NSC95397 | CTRPv2 | pan-cancer | AAC | -0.05 | 0.2 |
| mRNA | Lisitinib | GDSC1000 | pan-cancer | AAC | -0.058 | 0.2 |
| mRNA | BMS-195614 | CTRPv2 | pan-cancer | AAC | 0.058 | 0.2 |
| mRNA | GDC-0941 | CTRPv2 | pan-cancer | AAC | 0.055 | 0.2 |